| Date Filed | Type | Description |
| 10/11/2023 |
8-K
| Quarterly results |
| 08/16/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 08/14/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/14/2023 |
8-K
| Quarterly results |
| 07/26/2023 |
8-K
| Quarterly results |
| 06/07/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 06/07/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
| 06/07/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 05/12/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 04/14/2023 |
8-K
| Quarterly results |
| 03/28/2023 |
8-K
| Quarterly results |
| 03/22/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 03/22/2023 |
8-K
| Quarterly results |
| 03/13/2023 |
8-K
| Regulation FD Disclosure Interactive Data |
| 02/14/2023 |
SC 13G/A
| Mack Anthony P. reports a 26.1% stake in VIRPAX PHARMACEUTICALS, Inc. |
| 01/26/2023 |
SC 13G/A
| Kepos Capital LP reports a 0% stake in Virpax Pharmaceuticals, Inc. |
| 01/10/2023 |
SC 13G/A
| SABBY MANAGEMENT, LLC reports a 8.4% stake in Virpax Pharmaceuticals, Inc. |
| 12/29/2022 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Interact... |
| 11/22/2022 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 11/09/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 11/09/2022 |
8-K
| Quarterly results |
| 10/19/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 10/07/2022 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933: |
| 08/15/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 08/15/2022 |
8-K
| Quarterly results |
| 07/25/2022 |
8-K
| Quarterly results |
| 06/27/2022 |
8-K
| Quarterly results |
| 06/21/2022 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 06/15/2022 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 06/15/2022 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 05/16/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
| 05/16/2022 |
8-K
| Quarterly results |
| 05/06/2022 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 03/31/2022 |
8-K
| Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits I... |
|